Suchergebnisse - "Liu, Yuanbo"

PubPharm (6)

1

The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis

enthalten in: BMC cancer | 2022

von Zhang, X. | Wu, Y. | Sun, X. | +9

2

Interleukin-20 inhibits the osteogenic differentiation of MC3T3-E1 cells via the GSK3β/β-catenin signalling pathway

enthalten in: Archives of oral biology | 2021

von Chen, X. | Liu, Y. | Meng, B. | +3

3

Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways

enthalten in: Scandinavian journal of immunology | 2020

von Meng, B. | Wu, D. | Cheng, Y. | +5

4

Targeting the PI3K/AKT/mTOR Signaling Pathway in Primary Central Nervous System Lymphoma : Current Status and Future Prospects

enthalten in: CNS & neurological disorders drug targets | 2020

von Zhang, X. | Liu, Y.

5

MiR-21-5p Links Epithelial-Mesenchymal Transition Phenotype with Stem-Like Cell Signatures via AKT Signaling in Keloid Keratinocytes

enthalten in: Scientific reports | 2016

von Yan, L. | Cao, R. | Liu, Y. | +7

6

Regulation of sensitivity to TRAIL by the PTEN tumor suppressor

enthalten in: Vitamins and hormones | 2004

von Whang, Y. | Yuan, X. | Liu, Y. | +2

1
[1]